Methyl-CpG binding protein 2 (MECP2), a methyl-binding protein involved in DNA transcription activities, is inhibited by exosomal miR-194 and exosomal miR-132 in cisplatin-resistant BC cell lines [127,128]. This evidence concerns the gene MECP2 and breast cancer.